Home   Site Map
 Search 
MICROBIOLOGY PRODUCTS
IMMUNODIAGNOSTIC PRODUCTS
CELL BIOLOGY RESEARCH PRODUCTS
  Products Technical Library Events News About Contact Us Management Career Exchange login הזמנות  
   

StrepBStick One Step Test # R-6015

Group B streptococci are most notable for their role in causing neonatal sepsis and meningitis. Two forms of neonatal infection have been recognized on clinical and epidemiological grounds:

(a) Early onset disease, which usually occurs within the first 10 days after delivery.

(b) Late onset disease, which usually, though not always, occurs 10 days after birth. Late onset disease may be due to nosocomial acquisition of the organism and is rarely associated with material or obstetric complications. Early onset disease is thought to be due to acquisition, perhaps by aspiration, of the organism from the mother's genital tract at the time of delivery. The incidence of Group B Streptococci range from 1 to 5% of live births with mortality rates from 22 to 80%.  In order to properly treat the disease using antibiotic therapy, it is important to use an accurate diagnostic method to identify the pathologic agent. Different methods are currently used for detection of Group B Streptococci including cellular culture, immunofluorescence, enzyme immunoassay, or latex agglutination.

 

The One Step Strep B Stick test (Cat. No. R-6015) is a rapid qualitative one step assay for the detection of Streptococcus Group B antigen from vagina swab specimens.

 


FOR FURTHER INFORMATION EMAIL US OR CALL: +972-2-6781861


 

Related Documents
Click to Download : (1.3 Mb) Rapid Diagnosis of Group B Streptococcus
Click to Download : (63.9 Kb) StrepBStick Instructions - Pouch Version

 
Copyright © 2008 Novamed. All Rights Reserved. POB 53231 Jerusalem Israel Tel: 972-2-6781861 Fax: 972-2-6781852
Created by Catom web design